ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,152Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 393

$671K Total Retail Price of All Prescriptions

Rank: 29 out of 393

252 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 252 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 252 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 575 454 1 2
JANTOVEN 560 511 2 105
SIMVASTATIN 444 344 3 1
WARFARIN SODIUM 444 336 3 17
DONEPEZIL HCL 431 385 5 34
LEVOTHYROXINE SODIUM 429 348 6 3
NAMENDA 350 326 7 59
METFORMIN HCL 311 233 8 7
AMLODIPINE BESYLATE 307 227 9 4
HYDROCODONE-ACETAMINOPHEN 293 230 S3 10 5
ALENDRONATE SODIUM 272 258 11 16
FUROSEMIDE 270 199 12 8
RISPERIDONE 269 198 13 75
OXYCODONE-ACETAMINOPHEN 205 110 S2 14 71
OMEPRAZOLE 196 155 15 6
POTASSIUM CHLORIDE 193 133 16 20
GABAPENTIN 185 112 17 15
SERTRALINE HCL 177 94 18 28
GEMFIBROZIL 174 101 19 62
METOPROLOL TARTRATE 165 132 20 9
LOVASTATIN 157 121 21 14
ZOLPIDEM TARTRATE 148 124 22 11
QUETIAPINE FUMARATE 145 96 23 104
CARVEDILOL 133 89 24 21
ZETIA 130 77 25 103
FAMOTIDINE 121 89 26 70
LEVETIRACETAM 119 25 27 112
GLIPIZIDE 115 71 28 32
NOVOLOG FLEXPEN 113 67 29 127
DIVALPROEX SODIUM 110 66 30 124
CITALOPRAM HBR 109 95 31 23
RANITIDINE HCL 109 61 31 29
FELODIPINE ER 108 97 33 130
AMOX TR-POTASSIUM CLAVULANATE 106 79 34 100
CLOPIDOGREL 104 81 35 33
CLONIDINE HCL 102 51 36 50
PROMETHAZINE HCL 99 67 R 37 209
SODIUM CHLORIDE 97 91 38 164
TRIAMCINOLONE ACETONIDE 97 81 38 94
MIRTAZAPINE 96 84 40 89
MORPHINE SULFATE ER 95 60 S2 41 48
PRAVASTATIN SODIUM 88 55 42 18
LEVOFLOXACIN 86 67 43 95
FLUDROCORTISONE ACETATE 81 51 44 246
PAROXETINE HCL 79 70 45 61
ABILIFY 79 21 45 215
MIDODRINE HCL 79 38 45 247
HYDRALAZINE HCL 78 47 48 64
VANCOMYCIN HCL 76 71 49 171
ESCITALOPRAM OXALATE 76 44 49 133
TRAZODONE HCL 75 48 51 47
LOVAZA 74 23 52 114
MEGESTROL ACETATE 74 60 R 52 182
CARBIDOPA-LEVODOPA 74 71 52 142
PLAVIX 72 61 55 51
TAMSULOSIN HCL 71 57 56 25
LEVEMIR FLEXPEN 69 22 57 117
ENOXAPARIN SODIUM 67 45 58 183
OLANZAPINE 66 28 59 213
CEPHALEXIN 63 36 60 131
POLYETHYLENE GLYCOL 3350 63 36 60 99
FLUOXETINE HCL 63 57 60 37
CEFUROXIME 61 41 63 273
ALBUTEROL SULFATE 60 40 64 92
PANTOPRAZOLE SODIUM 59 38 65 56
OXYBUTYNIN CHLORIDE 58 37 66 90
PHENYTOIN SODIUM EXTENDED 57 33 67 200
CYMBALTA 56 15 68 88
CIPROFLOXACIN HCL 55 43 69 57
SANTYL 55 36 69 149
LOSARTAN POTASSIUM 52 50 71 12
BUPROPION HCL SR 52 19 71 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.